Skip to content

ICU Medical ICUI Indefinite-Lived Intangible Assets, Gross

Indefinite-Lived Intangible Assets, Gross at other companies

Haemonetics logo
HaemoneticsHAE

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's indefinite-lived intangible assets, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's indefinite-lived intangible assets, gross?
ICU Medical (ICUI) reported indefinite-lived intangible assets, gross of $7.58M in Q1 2026.
How has ICU Medical's indefinite-lived intangible assets, gross changed year-over-year?
ICU Medical's indefinite-lived intangible assets, gross decreased by 44.8% year-over-year, from $13.72M to $7.58M.
What is the long-term trend for ICU Medical's indefinite-lived intangible assets, gross?
Over 5 years (2020 to 2025), ICU Medical's indefinite-lived intangible assets, gross has grown at a -20.5% compound annual growth rate (CAGR), from $19.36M to $6.16M.